LONG-TERM EFFICACY AND SAFETY OF ODEVIXIBAT, AN ILEAL BILE ACID TRANSPORTER INHIBITOR IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: INTERIM RESULTS FROM PEDFIC 2, AN OPEN-LABEL PHASE 3 TRIAL